Sherrard D J, Goldberg A B, Haas L B, Brunzell J D
Nephron. 1980;25(5):219-21. doi: 10.1159/000181842.
21 hypertriglyceridemic hemodialysis patients were treated with 1--2 g/week of clofibrate. The dosage reduction from the usual clofibrate dose of 14 g/week avoided toxicity and corrected the abnormalities in serum triglyceride and high density lipoprotein cholesterol levels to or toward normal.
21名高甘油三酯血症血液透析患者接受了每周1至2克氯贝丁酯的治疗。从氯贝丁酯通常每周14克的剂量减少用量避免了毒性反应，并使血清甘油三酯和高密度脂蛋白胆固醇水平的异常恢复到正常或趋于正常。
